Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-γ in peripheral blood

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

(2017) Mika Shapiro et al.   HAEMATOLOGICA

LAG3 (CD223) as a cancer immunotherapy target

(2017) Lawrence P. Andrews et al.   IMMUNOLOGICAL REVIEWS

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

(2017) Mika Shapiro et al.   HAEMATOLOGICA

Lymphocyte-activation gene-3, an important immune checkpoint in cancer

(2016) Yayi He et al.   CANCER SCIENCE

Relationships between gastrointestinal symptoms, uncertainty, and perceived recovery in patients with gastric cancer after gastrectomy

(2016) Byeong Hee Jeon et al.   Nursing & Health Sciences

An increased number of PD-1+ and Tim-3+ CD8+ T cells is involved in immune evasion in gastric cancer

(2016) Shuichi Takano et al.   SURGERY TODAY

Interleukin 10 promotes immune response by increasing the survival of activated CD8+ T cells in human papillomavirus 16-infected cervical cancer

(2016) Li Li et al.   TUMOR BIOLOGY

LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma

(2016) Wei-Wei Deng et al.   OncoImmunology

LAG3 Expression in Active Mycobacterium tuberculosis Infections

(2015) Bonnie L. Phillips et al.   AMERICAN JOURNAL OF PATHOLOGY

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model

(2015) Ruea-Yea Huang et al.   Oncotarget

Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

(2014) T. Waddell et al.   EJSO

Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer

(2014) Keunwook Lee et al.   Gut and Liver

Targeting CD8+ T-cell tolerance for cancer immunotherapy

(2014) Stephanie R Jackson et al.   Immunotherapy

Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy

(2014) Chang Song et al.   OncoImmunology

Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8+ T Cells That Is Associated with Lower Viral Load

(2013) José Peña et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Gastric Cancer

(2013) Catherine de Martel et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-β1 in Gastric Cancer

(2013) Bin Deng et al.   PLoS One

Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer

(2013) Ming Sun et al.   TUMOR BIOLOGY

Roles of LAG3 and EGR2 in regulatory T cells

(2012) Tomohisa Okamura et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased tumor-infiltrating CD8+Foxp3+ T lymphocytes are associated with tumor progression in human gastric cancer

(2012) Liu-sheng Peng et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

ANALYSIS OF CD8+CD28−T-SUPPRESSOR CELLS IN GASTRIC CANCER PATIENTS

(2012) Yu Shen et al.   JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY

Functional heterogeneity of human effector CD8+ T cells

(2011) H. Takata et al.   BLOOD

Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme

(2011) F. Dhalla et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development

(2011) Gerritje J.W. van der Windt et al.   IMMUNITY

Retrospective analysis of prognostic outcome of gastric cancer in young patients

(2011) Rieko Nakamura et al.   International Journal of Clinical Oncology

A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1

(2011) Yongyong Shi et al.   NATURE GENETICS

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

(2011) Kai Wang et al.   NATURE GENETICS

Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

(2010) S. P. Kerkar et al.   CANCER RESEARCH

The CD4-like molecule LAG-3, biology and therapeutic applications

(2010) Sophie Sierro et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated Immunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival

(2010) Jana Kotaskova et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

(2010) Chrystelle Brignone et al.   Journal of Translational Medicine